Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
crawled time : 12:00 source : Ir.vaccinex.com save search
Vaccinex Reports Second Quarter 2023 Financial Results and Provides Corporate Update
Published: 2023-08-14 (Crawled : 12:00) - ir.vaccinex.com
VCNX | $4.8 -2.76% 7.9K
|
Health Technology
|
| O: -0.5%
H: 0.0%
C: -8.08%
CHRS | $2.06 3.0% 2.91% 2.9M
|
Health Technology
|
| O: -1.99%
H: 0.21%
C: -3.0%
update financial results
Vaccinex Completes Enrollment in Phase 1b/2 SIGNAL-AD (Alzheimer’s Disease) Study of Pepinemab
Published: 2023-04-25 (Crawled : 12:00) - ir.vaccinex.com
VCNX | $4.8 -2.76% 7.9K
|
Health Technology
|
| O: -0.1%
H: 2.75%
C: -2.19%
pepinemab study
Vaccinex New ActivMAb® application published in Nature Communications for Directed Evolution of GPCRs in Mammalian Cells
Published: 2023-04-12 (Crawled : 12:00) - ir.vaccinex.com
VCNX | $4.8 -2.76% 7.9K
|
Health Technology
|
| O: 0.02%
H: 2.44%
C: -2.29%
activmab communications application
Vaccinex Reports 2022 Financial Results and Provides Corporate Update of Continued Progress in Neurology and Oncology Clinical Programs
Published: 2023-04-03 (Crawled : 12:00) - ir.vaccinex.com
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: -0.27%
H: 1.91%
C: 1.62%
VCNX | $4.8 -2.76% 7.9K
|
Health Technology
|
| O: 0.13%
H: 10.0%
C: 5.5%
update financial results
Vaccinex, Inc. to Present at the 2023 AAIC Advancements: Immunity Conference
Published: 2023-03-23 (Crawled : 12:00) - ir.vaccinex.com
VCNX | $4.8 -2.76% 7.9K
|
Health Technology
|
| O: -3.01%
H: 2.54%
C: -1.03%
conference
Vaccinex, Inc. Announces Upcoming Presentation at the PEGS Boston Conference & Expo Highlighting Its ActivMAb® Technology for Complex Membrane Antigen Expression to Enable Drug Discovery
Published: 2022-04-25 (Crawled : 12:00) - ir.vaccinex.com
VCNX | $4.8 -2.76% 7.9K
|
Health Technology
|
| O: -0.8%
H: 2.42%
C: -1.61%
activmab drug conference technology presentation
Vaccinex to Present at the Virtual Huntington’s Study Group Meeting on November 4-6, 2021
Published: 2021-11-01 (Crawled : 12:00) - ir.vaccinex.com
VCNX | $4.8 -2.76% 7.9K
|
Health Technology
|
| O: -2.09%
H: 6.18%
C: 3.21%
huntington vaccine
Vaccinex to Chair Panel Q&A Session and Present Poster at the XV European Meeting on Glial Cells in Health and Disease
Published: 2021-06-30 (Crawled : 12:00) - ir.vaccinex.com
VCNX | $4.8 -2.76% 7.9K
|
Health Technology
|
| O: 0.37%
H: 3.66%
C: 2.56%
disease europe vaccine
Vaccinex to Present at the Jefferies 2021 Virtual Healthcare Conference
Published: 2021-05-19 (Crawled : 12:00) - ir.vaccinex.com
VCNX | $4.8 -2.76% 7.9K
|
Health Technology
|
| O: -5.44%
H: 6.68%
C: 3.9%
vaccine conference presentation
Vaccinex Reports Fourth Quarter 2020 Financial Results and Provides Corporate Update
Published: 2021-03-16 (Crawled : 12:00) - ir.vaccinex.com
LLY | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 1.26%
H: 0.04%
C: -0.33%
VCNX | $4.8 -2.76% 7.9K
|
Health Technology
|
| O: 7.81%
H: 8.13%
C: -5.16%
financial results results vaccine
Gainers vs Losers
| 60% | 40% |
Top 10 Gainers
AGBA | News | $1.305 226.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
INSG | $3.03 25.21% 330K
|
Electronic Technology
KNW 4 | $0.59 -0.71% 18.64% 27K
|
Manufacturing
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
ASNS | $0.828 21.75% 17.86% 18K
|
UONE | $2.36 19.8% 16.53% 75K
|
Consumer Services
RWOD | $9.54 19.3% 16.18% 6.1M
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.